// App-Quantinova.ai

P309 : IMAGE-BASED HIGH-CONTENT DRUG SENSITIVITY SCREENING IDENTIFIES CONVENTIONAL, EMERGING, AND POTENTIAL NOVEL THERAPEUTIC TARGETS IN HIGH-RISK ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Hayden Bell

Principal Investigators

  • Mankaran Singh

  • Helen Blair

  • Alistair Poll

  • Edward Law

  • Olaf Heidenreich

  • Frederik van Delft

  • Anthony Moorman

  • John Lunec

  • Julie Irving

Medical Centers

  • Wolfson Childhood Cancer Research Centre,Newcastle University,Newcastle upon Tyne,Vereinigtes Königreich

  • Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

  • Wolfson Childhood Cancer Research Centre,Newcastle University,Newcastle upon Tyne,Royaume-uni

  • Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

  • Wolfson Ch

  • Wolfson Childhood Cancer Research Centre,Newcastle University,Newcastle upon Tyne,Vereinigtes Königreich

  • Paul O

  • Prinses Maxima Centrum,Utrecht,Paesi Bassi

  • Prinses Maxima Centrum,Utrecht,Нидерланды

  • Princess Máxima Centrum,Utrecht,Holanda

  • Paul O'Gorman Building,Newcastle University,Newcastle upon Tyne,Royaume-uni

  • Wolfson Childhood Cancer Research Centre,Newcastle University,Newcastle upon Tyne,Vereinigtes Königreich

  • Prinses Maxima Centrum,Utrecht,Paesi Bassi

  • Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

  • Princess Máxima Centrum,Utrecht,Holanda

  • Princess Máxima Centrum,Utrecht,Holanda

  • Princess Maxima Center, Utrecht, Netherlands

  • Paul O'Gorman Building,Newcastle University,Newcastle upon Tyne,Vereinigtes Königreich

  • Princess Máxima Centrum,Utrecht,Holanda

  • Prinses Maxima Centrum,Utrecht,Paesi Bassi

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Mesenchymal stem cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A